China is transitioning towards concentrating tuberculosis
(TB) diagnostic and treatment services in hospitals, while the Centers of
Disease Control and Prevention (CDC) system will retain important public health
functions. Patient expenditure incurred through hospitalization may lead to
barriers to TB care or interruption of treatment.
We conducted a national survey of TB specialized hospitals
to determine hospitalization fees and hospital bed utilization in 1999, 2004,
and 2009. Hospitalization of TB patients increased 185.3% from 1999 to 2009.
While the average hospitalization fees also increased, the proportion of those
fees in relation to GDP per capita decreased. Hospitalization fees differed
across the three regions (eastern, central, and western). Using a least
standard difference (LSD) paired analysis, in 2004, the difference in
hospitalization fees was significant when comparing eastern and central provinces
(p<0.001) as well as to western
provinces (p<0.001).
In 2009, the difference remained statistically significant when comparing
eastern province hospitalization fees with central provinces (p<0.001) and western provinces
(p =
0.008). In 2004 and 2009, the cost associated with hospitalization as a
proportion of GDP per capita was highest in the western region. The average
in-patient stay decreased from 33 days in 1999 to 26 and 27 days in 2004 and
2009 respectively. Finally, hospital bed utilization in all three regions
increased over this period.
Our findings show that both the total number of in-patients
and hospitalization fees increased from 1999 to 2009, though the proportion of
hospitalization fees to GDP per capita decreased. As diagnostic services move
to hospitals, regulatory and monitoring mechanisms should be established, and
hospitals should make use of the experience garnered by the CDC system through
continued strong collaborations. Infrastructure and social protection
mechanisms in high burden areas, such as in the western region, should be
strengthened.
Below: Numbers of patients, per region, per year
Full article
at: http://goo.gl/0onS1Z
By:
Jian Du, Yan Ma, Fengling Mi, Yuhong Liu, Liang Li
Beijing Chest Hospital, Capital Medical University, Beijing,
China
Jian Du, Yan Ma, Fengling Mi, Yuhong Liu, Liang Li
Beijing Tuberculosis and Thoracic Tumor Research Institute,
Beijing, China
Jian Du, Yan Ma, Fengling Mi, Yuhong Liu, Liang Li
Administration Office, Clinical Center on Tuberculosis
Control, China CDC, Beijing, China
Dirlikov Emilio
Department of Anthropology, McGill University, Montreal,
Canada
Yu Pang
National Center for Tuberculosis Control and Prevention,
Chinese Center for Disease Control and Prevention, Beijing, China
More at: https://twitter.com/hiv_insight
No comments:
Post a Comment